| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
phenotype | 0.100 | None | 0.954 | 65 | 0 | 1991 | 2020 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
phenotype | 0.100 | None | 0.949 | 39 | 0 | 1993 | 2019 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 1995 | 2019 | |||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1998 | 2012 | |||||||||
|
TCR gamma alternate reading frame protein | 0.638 | 0.500 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 | |||||||||
|
T cell receptor gamma constant 1 | 0.663 | 0.385 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2010 | 2019 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2010 | 2019 | |||||||||
|
WT1 antisense RNA | 0.597 | 0.615 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 1994 | 2015 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2019 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2019 | |||||||||
|
immunoglobulin kappa locus | 0.647 | 0.462 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 1998 | 2017 | |||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | |||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1994 | 1998 | |||||||||
|
T cell receptor delta joining 1 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta diversity 3 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta constant | 0.729 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor beta variable 16 (gene/pseudogene) | 0.695 | 0.500 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2012 | |||||||||
|
T cell receptor beta variable 7-9 | 0.695 | 0.500 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2012 | |||||||||
|
T cell receptor beta constant 1 | 0.695 | 0.500 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2012 | |||||||||
|
Fanconi renotubular syndrome | 0.599 | 0.654 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | |||||||||
|
T cell receptor beta locus | 0.636 | 0.538 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2012 | |||||||||
|
T cell receptor delta locus | 0.650 | 0.692 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
H3 histone pseudogene 9 | 0.505 | 0.731 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2001 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2002 |